<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Taking the Longer View of COVIDâ€�19 Editorial ChabnerBruce A.1bruce.chabner@theoncologist.com[1], Massachusetts" exact="General" post="Hospital Cancer Center, Harvard Medical SchoolBostonMassachusettsUSA *Correspondence: Bruce A."/>
 <result pre="Longer View of COVIDâ€�19 Editorial ChabnerBruce A.1bruce.chabner@theoncologist.com[1], Massachusetts General Hospital" exact="Cancer" post="Center, Harvard Medical SchoolBostonMassachusettsUSA *Correspondence: Bruce A. Chabner, M.D.,"/>
 <result pre="Center, Harvard Medical SchoolBostonMassachusettsUSA *Correspondence: Bruce A. Chabner, M.D., Massachusetts" exact="General" post="Hospital Cancer Center, Boston, Massachusetts 02114, USA. Eâ€�mail: bruce.chabner@theoncologist.com"/>
 <result pre="Medical SchoolBostonMassachusettsUSA *Correspondence: Bruce A. Chabner, M.D., Massachusetts General Hospital" exact="Cancer" post="Center, Boston, Massachusetts 02114, USA. Eâ€�mail: bruce.chabner@theoncologist.com epub: 2020-4-4ppub:"/>
 <result pre="related to COVIDâ€�19 and how it impacts the care of" exact="cancer" post="patients:â€œCancer Research Ethics and COVIDâ€�19,â€� by Andrew G. Shuman"/>
 <result pre="â€œHow to Guarantee the Best of Care to Patients with" exact="Cancer" post="During the COVIDâ€�19 Epidemic: The Italian Experience,â€� by Giuseppe"/>
 <result pre="page e879 (online only)â€œA Practical Approach to the Management of" exact="Cancer" post="Patients During the Novel Coronavirus Disease 2019 (COVIDâ€�19) Pandemic:"/>
 <result pre="to the Management of Cancer Patients During the Novel Coronavirus" exact="Disease" post="2019 (COVIDâ€�19) Pandemic: An International Collaborative Group,â€� by Humaid"/>
 <result pre="and family relationships, and on our national economy. In the" exact="absence of" post="a vaccine or effective antivirals, social distancing is currently"/>
 <result pre="a vaccine or effective antivirals, social distancing is currently the" exact="primary" post="public health strategy for containing the epidemic and has"/>
 <result pre="effective vaccine against SARSâ€�CoVâ€�2 infection, in the U.S. the Biomedical" exact="Advanced" post="Research and Development Authority (BARDA) of the Department of"/>
 <result pre="Gates Foundation have implemented an international effort, the Coalition for" exact="Epidemic" post="Preparedness Innovation (CEPI), to select and promote the development"/>
 <result pre="distribution of an effective agent in the next year 3." exact="Multiple" post="other approaches to vaccine development are in play, including"/>
 <result pre="the use of DNA and mRNA vectors, as well as" exact="viral" post="proteins and peptide epitopes, delivered in different formulations and"/>
 <result pre="evidence that HQ has antiviral effects is minimal. It suppresses" exact="viral" post="replication only at very high, nonpharmacological drug concentrations 4."/>
 <result pre="the International Journal of Antimicrobial Agents5, describing a poorly performed," exact="uncontrolled" post="French study, which has been sharply criticized by the"/>
 <result pre="ill people. Hydroxychloroquine is not an innocuous agent. It causes" exact="retinal degeneration," post="myopathy, QT interval elongation, and rarely, ventricular arrhythmias. It"/>
 <result pre="patients with hepatic failure, which occurs with multiâ€�organ failure in" exact="acute" post="respiratory distress syndrome associated with COVIDâ€�19, the clearance of"/>
 <result pre="with hepatic failure, which occurs with multiâ€�organ failure in acute" exact="respiratory" post="distress syndrome associated with COVIDâ€�19, the clearance of hydroxychloroquine"/>
 <result pre="failure, which occurs with multiâ€�organ failure in acute respiratory distress" exact="syndrome" post="associated with COVIDâ€�19, the clearance of hydroxychloroquine is delayed,"/>
 <result pre="the benefit is difficult to assess 7. Favipiravir (Fujifilm), another" exact="viral" post="replication inhibitor designed for treatment of influenza, is also"/>
 <result pre="Selinexor, a candidate antiâ€�cancer drug that inhibits nuclear export of" exact="viral" post="proteins, is also the subject of expanded studies against"/>
 <result pre="expanded studies against COVIDâ€�19. Efforts to discover drugs for SARSâ€�CoVâ€�2" exact="infection" post="will likely identify more effective and specificallyâ€�targeted compounds 6."/>
 <result pre="pharmaceutical industry has had remarkable success developing antivirals against HIVâ€�AIDS," exact="hepatitis" post="B and C, and herpes viruses. There are obvious"/>
 <result pre="success developing antivirals against HIVâ€�AIDS, hepatitis B and C, and" exact="herpes" post="viruses. There are obvious SARSâ€�CoVâ€�2 targets: the viral reverse"/>
 <result pre="C, and herpes viruses. There are obvious SARSâ€�CoVâ€�2 targets: the" exact="viral" post="reverse transcriptase necessary for replication, a protease TMPRSS2 required"/>
 <result pre="protease TMPRSS2 required to cleave the spike protein that provides" exact="viral" post="entry 8, the ACE2 receptor on lung epithelium that"/>
 <result pre="common ACE2 receptor inhibitors now used as antiâ€�hypertensives would block" exact="viral" post="entry and mitigate infection. Single agent antiviral therapy may"/>
 <result pre="in combination (as they are now used against HIV and" exact="hepatitis" post="infection) could be invaluable in prophylaxis against infection and"/>
 <result pre="HIV and hepatitis infection) could be invaluable in prophylaxis against" exact="infection" post="and in treating infection before it becomes lifeâ€�threatening. A"/>
 <result pre="could be invaluable in prophylaxis against infection and in treating" exact="infection" post="before it becomes lifeâ€�threatening. A recent article in Science9"/>
 <result pre="potent antiviral activity of bertaâ€�Dâ€�N4 hydroxycytidine against SARSâ€�CoVâ€�2 in human" exact="epithelial" post="airway cultures. In vivo studies against the MERS and"/>
 <result pre="the MERS and SARS viruses (but not against SARSâ€�CoVâ€�2) showed" exact="partial" post="protection against lung injury, but the effect was dependent"/>
 <result pre="release of cytokines appears to play a central role in" exact="pulmonary" post="edema, inflammation, and respiratory failure associated with COVIDâ€�19 10."/>
 <result pre="to play a central role in pulmonary edema, inflammation, and" exact="respiratory" post="failure associated with COVIDâ€�19 10. Although evidence is preliminary,"/>
 <result pre="Hoffmanâ€�La Roche and sarilumab from Sanofi) are currently approved for" exact="rheumatoid arthritis" post="and have anecdotal efficacy in treating side effects of"/>
 <result pre="Roche and sarilumab from Sanofi) are currently approved for rheumatoid" exact="arthritis" post="and have anecdotal efficacy in treating side effects of"/>
 <result pre="arthritis and have anecdotal efficacy in treating side effects of" exact="cancer" post="immunotherapy. Multiple trials of antiâ€�ILâ€�6 receptor antibody in ventilatorâ€�dependent"/>
 <result pre="have anecdotal efficacy in treating side effects of cancer immunotherapy." exact="Multiple" post="trials of antiâ€�ILâ€�6 receptor antibody in ventilatorâ€�dependent COVIDâ€�19 infection"/>
 <result pre="immunotherapy. Multiple trials of antiâ€�ILâ€�6 receptor antibody in ventilatorâ€�dependent COVIDâ€�19" exact="infection" post="are under way. An inhibitor of the JAK2â€�STAT pathway"/>
 <result pre="hyperimmune serum as passive treatment of desperately ill patients. Very" exact="limited" post="experience, anecdotal at best, suggests that antibodies can mitigate"/>
 <result pre="limited experience, anecdotal at best, suggests that antibodies can mitigate" exact="infection" post="in these patients 11. Companies are investigating the development"/>
 <result pre="by the current epidemic. Vastly improved preparedness, early deployment of" exact="viral" post="testing, and quarantine of infected individuals will help limit"/>
 <result pre="will divert resources from other areas of medical research, including" exact="cancer" post="research, for the foreseeable future, but we have no"/>
 <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARSâ€�CoVâ€�2" exact="infection" post="in vitro. Cell Discov2020;6:16.32194981 9SheehanTP, SimsAC, ZhouS et al."/>
 <result pre="orally bioavailable broad spectrum antiviral inhibits SARSâ€�CoVâ€�2 in human airway" exact="epithelial" post="cell cultures and multiple coronaviruses in mice. Science2020 [Epub"/>
</results>
